<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35481849</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1473-5687</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of gastroenterology &amp; hepatology</Title>
          <ISOAbbreviation>Eur J Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?</ArticleTitle>
        <Pagination>
          <StartPage>724</StartPage>
          <MedlinePgn>724</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/MEG.0000000000002326</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Giri</LastName>
            <ForeName>Suprabhat</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Seth GS Medical College and KEM Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sundaram</LastName>
            <ForeName>Sridhar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Digestive Diseases and Clinical Nutrition, TATA Memorial Hospital, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Eur J Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>9000874</NlmUniqueID>
        <ISSNLinking>0954-691X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>H789N3FKE8</RegistryNumber>
          <NameOfSubstance UI="D001418">Baclofen</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N4K14YGM3J</RegistryNumber>
          <NameOfSubstance UI="D000077443">Acamprosate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000077443" MajorTopicYN="N">Acamprosate</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000428" MajorTopicYN="N">Alcohol Drinking</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000437" MajorTopicYN="Y">Alcoholism</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001418" MajorTopicYN="N">Baclofen</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>10</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35481849</ArticleId>
        <ArticleId IdType="doi">10.1097/MEG.0000000000002326</ArticleId>
        <ArticleId IdType="pii">00042737-202206000-00018</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Tyson LD, Cheng A, Kelleher C, Strathie K, Lovendoski J, Habtemariam Z, et al. Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis. Eur J Gastroenterol Hepatol 2021. doi: 10.1097/MEG.0000000000002304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MEG.0000000000002304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Addolorato G, Mirijello A, Leggio L, Ferrulli A, Landolfi R. Management of alcohol dependence in patients with liver disease. CNS Drugs 2013; 27:287–299.</Citation>
        </Reference>
        <Reference>
          <Citation>Pinot J, Rigal L, Granger B, Sidorkiewicz S, Jaury P. Tailored-dose baclofen in the management of alcoholism: a retrospective study of 144 outpatients followed for 3 years in a French general practice. Front Psychiatry 2018; 9:486.</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar A, Sharma A, Bansal PD, Bahetra M, Gill HK, Kumar R. A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence. Indian J Psychiatry 2020; 62:650–658.</Citation>
        </Reference>
        <Reference>
          <Citation>Mishra SN, Sarkar P, Shukla RK, Swain SP. A study of comparative efficacy of baclofen vs acamprosate in reducing alcohol craving and abuse. Orissa J Psychiatry 2010; 52:S69.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
